Invasive pneumococcal disease in Danish children, 1996-2007, prior to the introduction of heptavalent pneumococcal conjugate vaccine
- 3 November 2008
- journal article
- Published by Wiley in Acta Paediatrica
- Vol. 98 (2) , 328-331
- https://doi.org/10.1111/j.1651-2227.2008.01080.x
Abstract
The aim of this study was to document the epidemiology, microbiology and outcome of invasive pneumococcal disease (IPD) among children /=2 years. Our data indicate that an estimated 75% of all IPD cases among children <2 years are caused by PCV7 serotypes and might therefore be prevented by PCV7 vaccination.Keywords
This publication has 15 references indexed in Scilit:
- Changing Epidemiology of Pneumococcal Meningitis after the Introduction of Pneumococcal Conjugate Vaccine in the United StatesClinical Infectious Diseases, 2008
- Invasive pneumococcal disease: epidemiology in children and adults prior to implementation of the conjugate vaccine in the Oxfordshire region, EnglandJournal of Medical Microbiology, 2008
- Epidemiology of Invasive Pneumococcal Disease in BC during the Introduction of Conjugated Pneumococcal VaccineCanadian Journal of Public Health, 2008
- Streptococcus pneumoniae in western Europe: serotype distribution and incidence in children less than 2 years oldThe Lancet Infectious Diseases, 2006
- Invasive Pneumococcal Disease Among Infants Before and After Introduction of Pneumococcal Conjugate VaccineJAMA, 2006
- The potential indirect effect of conjugate pneumococcal vaccinesVaccine, 2003
- Invasive Pneumococcal Infections in Denmark from 1995 to 1999: Epidemiology, Serotypes, and ResistanceClinical and Vaccine Immunology, 2002
- The Changing Epidemiology of Bacterial Meningitis and Invasive Non-meningitic Bacterial Disease in Scotland During the Period 1983-99Scandinavian Journal of Infectious Diseases, 2002
- Invasive Pneumococcal Infections in Southwestern Sweden: A Second Follow-up Period of 15 YearsScandinavian Journal of Infectious Diseases, 2001
- Policy Statement: Recommendations for the Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate Vaccine (Prevnar), Pneumococcal Polysaccharide Vaccine, and Antibiotic ProphylaxisPediatrics, 2000